Kangkang Zhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Kangkang Zhi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ji Zhang
College of Life Science, Northwest Normal University, Lanzhou, China
1 shared publication - Jiajia Cui
College of Life Science, Northwest Normal University, Lanzhou 730070, China
1 shared publication - Shujuan Mi
College of Life Science, Northwest Normal University, Lanzhou 730070, China
1 shared publication - Wen Zhang
College of Life Sciences, Northwest Normal University, Lanzhou 730070, China; New Rural Development Research Institute, Northwest Normal University, Lanzhou 730070, China
1 shared publication - Xinxin He
College of Life Science, Northwest Normal University, Lanzhou 730070, China
1 shared publication
Latest Publications
- Open Access
- 29 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8255
Advancements in Non-Addictive Analgesic Diterpenoid Alkaloid Lappaconitine: A Review
The perennial herb Aconitum sinomontanum Nakai (Ranunculaceae) has been utilized as a traditional oriental medicine in China for numerous years. The principal pharmacological constituent of A. sinomontanum, lappaconitine (LA), exhibits analgesic, anti-inflammatory, anti-tumor, anti-arrhythmic, and anti-epileptic activities. Due to its potent efficacy and non-addictive nature, LA is widely utilized in the management of cancer pain and postoperative analgesia. This review encompasses the research advancements pertaining to LA including extraction methods, separation techniques, pharmacological properties, chemical modifications, and clinical applications. Additionally, it offers insights into the potential applications and current challenges associated with LA to facilitate future research endeavors.
- 29 July 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (15) , 8255
Open AccessAdvancements in Non-Addictive Analgesic Diterpenoid Alkaloid Lappaconitine: A Review
The perennial herb Aconitum sinomontanum Nakai (Ranunculaceae) has been utilized as a traditional oriental medicine in China for numerous years. The principal pharmacological constituent of A. sinomontanum, lappaconitine (LA), exhibits analgesic, anti-inflammatory, anti-tumor, anti-arrhythmic, and anti-epileptic activities. Due to its potent efficacy and non-addictive nature, LA is widely utilized in the management of cancer pain and postoperative analgesia. This review encompasses the research advancements pertaining to LA including extraction methods, separation techniques, pharmacological properties, chemical modifications, and clinical applications. Additionally, it offers insights into the potential applications and current challenges associated with LA to facilitate future research endeavors.